Background: COVID-19 prognostic factors include age, sex, comorbidities, laboratory and imaging findings, and time from symptom onset to seeking care.

Purpose: The study aim was to evaluate indices combining disease severity measures and time from disease onset to predict mortality of COVID-19 patients admitted to the emergency department (ED).

Materials And Methods: All consecutive COVID-19 patients who underwent both computed tomography (CT) and chest X-ray (CXR) at ED presentation between 27/02/2020 and 13/03/2020 were included. CT visual score of disease extension and CXR Radiographic Assessment of Lung Edema (RALE) score were collected. The CT- and CXR-based scores, C-reactive protein (CRP), and oxygen saturation levels (sO2) were separately combined with time from symptom onset to ED presentation to obtain severity/time indices. Multivariable regression age- and sex-adjusted models without and with severity/time indices were compared. For CXR-RALE, the models were tested in a validation cohort.

Results: Of the 308 included patients, 55 (17.9%) died. In multivariable logistic age- and sex-adjusted models for death at 30 days, severity/time indices showed good discrimination ability, higher for imaging than for laboratory measures (AUCCT = 0.92, AUCCXR = 0.90, AUCCRP = 0.88, AUCsO2 = 0.88). AUCCXR was lower in the validation cohort (0.79). The models including severity/time indices performed slightly better than models including measures of disease severity not combined with time and those including the Charlson Comorbidity Index, except for CRP-based models.

Conclusion: Time from symptom onset to ED admission is a strong prognostic factor and provides added value to the interpretation of imaging and laboratory findings at ED presentation.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202871PMC
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0270111PLOS

Publication Analysis

Top Keywords

severity/time indices
16
disease severity
12
time symptom
12
symptom onset
12
indices combining
8
combining disease
8
time disease
8
disease onset
8
onset predict
8
covid-19 patients
8

Similar Publications

Experiences and Challenges Updating a Living Evidence-Based Review of Randomized Controlled Trials on Mental Health and Behavioral Disorders in Individuals With Moderate to Severe Traumatic Brain Injury.

J Head Trauma Rehabil

September 2024

Author Affiliations: Lawson Health Research Institute, Lawson Research Institute, London, ON, Canada (Drs Teasell, MacKenzie, Flores-Sandoval, McIntyre, Barua, Mehta, and Bateman); Department of Physical Medicine and Rehabilitation, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada (Dr Teasell, MacKenzie, Mehta, and Bateman); Parkwood Institute, St. Joseph's Health Care London, London, Ontario, Canada (Drs Teasell, MacKenzie, and Bateman); Arthur Labatt School of Nursing, Western University, London, Ontario, Canada (Dr McIntyre); Division of Physical Medicine and Rehabilitation, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada (Dr Bayley); KITE Research Institute, University Health Network, Toronto, Ontario, Canada (Dr Bayley) University Health Network, Toronto Rehabilitation Institute, Toronto, Ontatio, Canada (Dr Bayley).

Objective: To describe experiences and challenges when updating a living evidence-based review database of randomized controlled trials (RCTs) on mental health and behavioral disorders in moderate to severe traumatic brain injury (MSTBI).

Method: This commentary derives from our experience developing an extensive database of RCTs on MSTBI that has been conceptualized as a living evidence-based review. Our working group focused on mental health and behavior RCTs and reflected upon their experiences and challenges using the living systematic approach.

View Article and Find Full Text PDF
Article Synopsis
  • An mRNA-based vaccine, mRNA-1345, is being tested in older adults (ages 65-79) to combat respiratory syncytial virus (RSV) and its associated health risks.
  • In a phase 1 trial, the vaccine showed good safety and tolerability, with common side effects including injection site pain, fatigue, and headaches, particularly after the booster dose.
  • Immunogenicity results indicated that a single dose significantly boosted antibody levels against RSV, and these levels remained elevated for 12 months after the initial shot and also increased with the booster.
View Article and Find Full Text PDF

Background: Empirical evidence has shown that light therapy (LT) can reduce depression symptoms by stimulating circadian rhythms. However, there is skepticism and inconclusive results, along with confusion regarding dosing. The purpose of this study is to quantify light as a stimulus for the circadian system and create a dose-response relationship that can help reduce maladies among adolescents and young adults (AYAs).

View Article and Find Full Text PDF

Effects of chronic psychosocial stress on 'binge-like' sucrose intake in mice.

Prog Neuropsychopharmacol Biol Psychiatry

January 2023

Division of Biochemistry, Department of Medicine, University of Fribourg, CH-1700 Fribourg, Switzerland.

Binge eating episodes are persistent and are essential features of numerous eating disorders (EDs). Susceptibility to EDs is largely presumed to be associated with early life stress. In fact, converging evidence from preclinical animal studies have implicated stress as a driver of binge eating.

View Article and Find Full Text PDF

Fine motor impairments are frequent complaints in people with Parkinson's disease (PD). While they may develop at an early stage of the disease, they become more problematic as the disease progresses. Tremors and fine motor symptoms may seem related, but evidence suggests two distinct phenomena.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!